The Indian Journal of Pediatrics

, Volume 79, Issue 6, pp 813–814

Symptomatic Myocarditis in Kawasaki Disease

  • Pooja Aggarwal
  • Deepti Suri
  • Nidhi Narula
  • Rohit Manojkumar
  • Surjit Singh
Clinical Brief


Kawasaki disease (KD) is an acute febrile illness of infants and young children that is characterized by a medium vessel vasculitis, most commonly involving the coronary arteries. Though subclinical myocarditis is rather common in KD, symptomatic congestive heart failure is extremely uncommon. The authors report a 9-y-old boy who developed heart failure (ejection fraction 28%) in the acute phase of KD. He was initially treated with intravenous immunoglobulin (2 g/kg) without much clinical improvement. He was then given 5 daily pulses of intravenous methylprednisolone followed by tapering doses of oral prednisolone. The child showed prompt clinical recovery and remains well on follow-up. The present case serves to highlight the fact that methylprednisolone can be considered upfront as rescue therapy in children with KD who have symptomatic congestive cardiac failure during the acute stage of the disease.


Kawasaki disease Congestive heart failure North India Methylprednisolone 


  1. 1.
    Kato H, Inoue O, Akagi T. Kawasaki disease: cardiac problems and management. Pediatr Rev. 1988;9:209–17.PubMedCrossRefGoogle Scholar
  2. 2.
    Takahashi M. Myocarditis in Kawasaki syndrome. A minor villain? Circulation. 1989;79:1398–400.PubMedCrossRefGoogle Scholar
  3. 3.
    Shinohara T, Yokoyama T. Clinical study of cardiac pump failure in acute phase of Kawasaki disease. J Pediatr Pract. 1999;62:2101–4.Google Scholar
  4. 4.
    Kato E, Asai T, Hayashi S, Morishita M, Ieda K, Yamaguchi H. Adolescent onset Kawasaki disease with cardiogenic shock. Jpn J Pediatr. 2000;53:47–52.Google Scholar
  5. 5.
    Fung AWC, Ng YM. An unusual presentation of Kawasaki disease. HK J Paediatr (New Series). 2002;7:104–6.Google Scholar
  6. 6.
    Yoshikawa H, Nomura Y, Masuda K, et al. Four Cases of Kawasaki Syndrome Complicated with Myocarditis. Circ J. 2006;70:202–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Singh S, Gupta MK, Bansal A, Manojkumar R, Mittal BR. A comparison of the clinical profile of Kawasaki disease in children from Northern India above and below 5 years of age. Clin Exp Rheumatol. 2007;25:654–7.PubMedGoogle Scholar
  8. 8.
    Kushner HI, Macnee R, Burns JC. Impressions of Kawasaki disease in India. Indian Pediatr. 2006;43:939–41.PubMedGoogle Scholar
  9. 9.
    Checchia PA, Borensztajn J, Shulman ST. Circulating cardiac troponin 1 levels in Kawasaki disease. Pediatr Cardiol. 2001;22:102–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Newburger JW, Sleeper LA, McCrindle BW, et al. Randomized trial of pulse steroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007;356:663–75.PubMedCrossRefGoogle Scholar
  11. 11.
    Newburger JW, Fulton DR. Kawasaki disease. Curr Treat Options Cardiovasc Med. 2007;9:148–58.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2011

Authors and Affiliations

  • Pooja Aggarwal
    • 1
  • Deepti Suri
    • 1
  • Nidhi Narula
    • 2
  • Rohit Manojkumar
    • 2
  • Surjit Singh
    • 1
  1. 1.Division of Allergy Immunology, Department of Pediatrics, Advanced Pediatrics CenterPost Graduate Institute of Medical Education and ResearchChandigarhIndia
  2. 2.Department of CardiologyPost Graduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations